PRESS RELEASE, 25 October 2019

Iconovo AB (publ) makes a significant investment in the development of a new inhalation platform

Iconovo AB (publ) announced today that the company has made a decision to invest in the development of a new dry powder inhalation platform. This platform will comprise a new inhalation device, ICOpre, and bespoke dry powder formulations. The new products are developed to target the global market including the US. Read more